ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
General Health & Fitness
Health & Wellness
Poor Quality Control In The Pharmaceutical Industry: A Report
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="dnfuss" data-source="post: 134388" data-attributes="member: 15487"><p>Pathetic, but sadly not surprising. Agree that much higher standard of quality control is required. That would mandate a higher level of regulatory agency funding. Good luck on that. On a policy level, the most egregious problem is advertising. There are only two developed nations that permit direct-to-consumer advertising of prescription drugs: the United States and (oddly) New Zealand. As noted, drug companies in the United States now spend far more on marketing than on R&D. Every doctor I've ever spoken with about this issue finds it concerning. Such advertising was first allowed in 1985, but for technical reasons was limited to print until 1997, when it first came to television. Reverting this statutory mistake should be on the top of every list of needed health care reforms, but consciousness of its significance, even among serious policy wonks, seems minimal, and the opposition to it from the pharmaceutical industry would be ferocious.</p></blockquote><p></p>
[QUOTE="dnfuss, post: 134388, member: 15487"] Pathetic, but sadly not surprising. Agree that much higher standard of quality control is required. That would mandate a higher level of regulatory agency funding. Good luck on that. On a policy level, the most egregious problem is advertising. There are only two developed nations that permit direct-to-consumer advertising of prescription drugs: the United States and (oddly) New Zealand. As noted, drug companies in the United States now spend far more on marketing than on R&D. Every doctor I've ever spoken with about this issue finds it concerning. Such advertising was first allowed in 1985, but for technical reasons was limited to print until 1997, when it first came to television. Reverting this statutory mistake should be on the top of every list of needed health care reforms, but consciousness of its significance, even among serious policy wonks, seems minimal, and the opposition to it from the pharmaceutical industry would be ferocious. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
General Health & Fitness
Health & Wellness
Poor Quality Control In The Pharmaceutical Industry: A Report
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top